Compare CPF & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPF | QDEL |
|---|---|---|
| Founded | 1954 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 918.5M | 1.0B |
| IPO Year | 2011 | 2022 |
| Metric | CPF | QDEL |
|---|---|---|
| Price | $35.55 | $13.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $37.00 | $28.25 |
| AVG Volume (30 Days) | 105.6K | ★ 1.5M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | 45.18 | ★ 45.35 |
| EPS | ★ 0.78 | N/A |
| Revenue | $51,817,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | $4.62 | $3.86 |
| P/E Ratio | $45.79 | ★ N/A |
| Revenue Growth | ★ 33.81 | N/A |
| 52 Week Low | $25.62 | $9.92 |
| 52 Week High | $37.01 | $35.58 |
| Indicator | CPF | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 52.02 |
| Support Level | $33.33 | $12.87 |
| Resistance Level | N/A | $17.78 |
| Average True Range (ATR) | 0.81 | 1.06 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 66.18 | 36.28 |
Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services. It operates in single segment which is Banking operations.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.